as of December 12, 2025
Timetable
Brief Program (English Sessions only)
Presidential Symposium
Sunday, March 1, 2026, 13:05～14:35
Advancing Hematopoietic Cell Transplantation Through Clinical Research
- Chairs
- Takahiro Fukuda
- （National Cancer Center Hospital, Japan）
- Takanori Teshima
- （Department of Hematology, Hokkaido University Faculty of Medicine, Japan）
Advancing HCT Through Registries: A Framework for Quality, Research, and Future Innovation
- Presenters
- Yoshiko Atsuta
- （Japanese Data Center for Hematopoietic Cell / Transplantation Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Japan）
Development of Nonmyeloablative and Reduced Intensity HCT: Past, Present and Future
- Brenda M. Sandmaier
-
（Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, USA / Division of Hematology and Oncology, University of Washington School of Medicine, USA）
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Advancing Clinical Research in Hematopoietic Cell Transplantation (HCT) and Cellular Immunotherapy (CIT)
- Mary M. Horowitz
- （Medical College of Wisconsin, USA）
Symposium 2
Saturday, February 28, 2026, 13:00～14:30
CD19-CAR-T Cell Therapy
- Chairs
- Koji Kato
- （Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan）
- Tomizawa Daisuke
- （Children's Cancer Center, National Center for Child Health and Development, Japan）
CAR-T Cell Therapy for Large B-Cell Lymphoma
- Presenters
- Caron Jacobson
- （Harvard Medical School / Dana-Farber Cancer Institute, USA）
The Role of CAR-T Cell Therapy for Pediatric and Young Adult Acute Lymphoblastic Leukemia
- Itaru Kato
- （Department of Pediatrics, Kyoto University, Japan）
Establishing Systems to Improve Access to CAR-T Therapy
- Koji Kato
- （Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Japan）
JSTCT-KSBMT Joint Symposium
Saturday, February 28, 2026, 8:50～10:20
HCT for lymphoma: Recent trends in CAR-T era
- Chairs
- Hyeon-Seok Eom
- （Center for Hematologic Malignancy, Department of Hematology-Oncology, National Cancer Center, Korea）
- Takanori Teshima
- （Department of Hematology, Hokkaido University Faculty of Medicine, Japan）
Role of hematopoietic cell transplantation in patients with peripheral T-cell lymphomas
- Presenters
- Dong Won Baek
- （Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Korea）
Where Does Transplant Still Matter in ENKTL?
Defining the Roles of Auto- and Allo-HSCT Amid Emerging Cellular Immunotherapy
- Young-Woo Jeon
- （Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Korea）
Outcomes of Hematopoietic Stem Cell Transplantation for Mature NK/T-cell Neoplasms in Japan
- Ayumi Fujimoto
- （Pathology Project for Molecular Targets, Cancer Institute, Tokyo, Japan）
Allo-HSCT in Lymphoma: Reframing Its Role in the Era of Novel agents and Cellular Therapies
- Mizuki Watanabe
- （National Cancer Center Hospital, Dept. Hematopoietic Stem Cell Transplantation / Division of Clinical Genetics Units, Japan）
Luncheon Seminar
Luncheon Seminar 14
Venue 14 Saturday, February 28, 2026, 11:55～12:45
- Chairs
- Kensuke Kojima
- （Department of Hematology, Kochi Medical School, Kochi University）
The strategy of time-limited combination therapies in CLL
- Presenters
- Arnon Kater
- （Department of Hematology, AMSTERDAM UNIVERSITY MEDICAL CENTERS, UNIVERSITY OF Amsterdam）
Co-sponsored by Johnson & Johnson
Luncheon Seminar 17
Venue 3 Sunday, March 1, 2026, 12:00～12:50
- Chairs
- Yoshiko Atsuta
- （The Japanese Data Center for Hematopoietic Cell Transplantation）
Optimizing CAR T Cell Therapy: Insights from Real-World Data and Clinical Practice
- Presenters
- Caron A. Jacobson
- （Immune Effector Cell Therapy Program, Medical Oncology, Dana-Farber Cancer Institute）
Co-sponsored by Gilead Sciences K.K.
Sweets Seminar
Sweets Seminar 7
Venue 8 Saturday, February 28, 2026, 16:10～17:00
Fungal infections associated with hematologic disorders
- Chairs
- Kazuhiro Ikegame
- （Aichi Medical University Hospital Hematopoietic Cell Transplantation Center）
Latest Insights into Drug-Drug Interactions of Antifungal Agents – A Global Perspective
- Presenters
- Mark Jones
- （Basilea Pharmaceutica Ltd）
Drug–Drug interactions of antifungal agents: Latest evidence and management in clinical practice in Japan
- Junya Kanda
- （Department of Hematology, Graduate School of Medicine, Kyoto University）
Co-sponsored by ASAHI KASEI PHARMA CORPORATION
